• Lorena Castro, Nidia Fabiola Castro, María Luz Endeiza, and GabrielmezzanoCentro de Enfermedades Digestivas Clínica, Universidad de los Andes, Santiago, Chile..
• Centro de Enfermedades Digestivas Clínica, Universidad de los Andes, Santiago, Chile.
• Rev Med Chil. 2023 Apr 1; 151 (4): 489496489-496.

AbstractPatients with cirrhosis and liver transplantation (LT) have a higher risk of infections, complications and death. Vaccines have historically been used to prevent and reduce the risk of complications from viral and bacterial infections. The population with cirrhosis and candidates for LT should be evaluated for immunity against the most relevant immuno-preventable infections, update corresponding immunizations according to the national vaccination program, and inoculate the missing vaccines based on these recommendations. In case of not reaching its inoculation prior to LT, in the post-LT period its vaccination status should be updated. All doctors involved in the health care of these patients must have knowledge about this important topic and be aware of the access and free availability for this population through the presentation of a special form incorporated into the National Immunization Program.

7 keywords...

hide…